Treatment optimisation in drug development  : study : Panel for the Future of Science and Technology  / EPRS - European Parliamentary Research Service 
.-- Brussels :  European Union,  March 2020 
.-- V, 70 p.  ; 1 documento PDF 
<br/><br/>Bibliografía: p. 66-70 
<br/><br/> The development of novel health technologies is a complex and costly process that follows an extensive set of regulatory guidelines and legal provisions intended to ensure that the treatments reach the patients that need them in a highly controlled and standardised manner 
<br/><br/> Reproduction and translation for non-commercial purposes are authorised, provided the source is acknowledged and the European Parliament is given prior notice and sent a copy. 
<br/><br/><label>ISBN: </label>978-92-846-6037-7   
<br/><br/><label>Núm. Estándar: </label>10.2861/114406  doi 
<br/><br/><label><b>Materias:</b></label> Sanidad digital<br/>
<br/><br/><label><b>Términos de indización - No controlado:</b> </label>treatment optimisation  <br/>clinical drug  <br/>treatment  <br/>patient  <br/>public health  <br/>industry  <br/>
<br/><br/><label><b>Encabezamiento secundario--Nombre de entidad:</b> </label> Parlamento Europeo. Dirección General de Servicios de Estudios Parlamentarios <br/>